Laddar...
Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia
Children with multiple relapsed or refractory leukemia have dismal survival. Research has identified engagement of immune checkpoint receptors (e.g., PD-1, PD-L1 and CTLA-4) as a mechanism for treatment resistance. For adult cancer, inhibitors of PD-1 (nivolumab) and CTLA-4 (ipilimumab) have shown p...
Sparad:
| I publikationen: | Int J Hematol Oncol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Future Medicine Ltd
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6410023/ https://ncbi.nlm.nih.gov/pubmed/30863527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2018-0009 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|